Nov 20, 2019 / 03:55PM GMT
Annabel Eva Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division - MD
Good morning, everyone, and welcome to the Bausch Health presentation. It's our pleasure to have CEO Joe Papa here with us who, I think, has orchestrated probably one of a tremendous feat, I would say from 3 years ago. And it's fair to say that Bausch is in a relatively stable position right now. I think you've got probably 75% to 80% of your revenues in a growth phase -- in a state of growth as opposed to a state of decline. Obviously, there's still a couple of areas of work to do. So obviously, that's getting dermatology back on track and getting the leverage back to a much more reasonable level. But you are well on your way.
So why don't I let you take a few minutes, give everyone a lay of the land, and then we can just launch into Q&A.
Joseph C. Papa - Bausch Health Companies Inc. - CEO & Chairman of the Board
Sure. So it's a pleasure to be here with everyone. It's a chance to talk about some of the things that we've been working very hard at Bausch
Bausch Health Companies Inc at Stifel Healthcare Conference Transcript
Nov 20, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers